Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6087]

Europe’s health policies ‘must change’ with stakeholders leaving their ‘comfort zones’

Europe’s health policies ‘must change’ with stakeholders leaving their ‘comfort zones’

Golden age of prostate cancer drug discovery and development as NICE draft guidance recommends new prostate cancer drug

Golden age of prostate cancer drug discovery and development as NICE draft guidance recommends new prostate cancer...

Patient advocate groups protest anachronistic Dutch Medicines Act at 2013 European Cancer Congress

Patient advocate groups protest anachronistic Dutch Medicines Act at 2013 European Cancer Congress

ECC 2013: First estimate of amount of radiotherapy dose wasted in compensating for tumour growth between treatments

ECC 2013: First estimate of amount of radiotherapy dose wasted in compensating for tumour growth between treatments

Cancer Research Technology and Teva Pharmaceuticals form R&D alliance for cancer DNA damage response drugs

Cancer Research Technology and Teva Pharmaceuticals form R&D alliance for cancer DNA damage response drugs

Ponatinib gains marketing authorization in the European Union

Ponatinib gains marketing authorization in the European Union

Half of UK will get cancer in their lifetime by 2020

Half of UK will get cancer in their lifetime by 2020

ASCO 2013: Surveys reveal shortages of common cancer drugs are ongoing in US

ASCO 2013: Surveys reveal shortages of common cancer drugs are ongoing in US

Brazil and Qatar join the International Agency for Research on Cancer

Brazil and Qatar join the International Agency for Research on Cancer

Access to cancer drugs in low and middle-income countries

Access to cancer drugs in low and middle-income countries

More from ecancer